Patent · US Expired

Methods and reagents for protease inhibition

US7029877B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Resear · CH

Inventors

Hugo Albrecht · Riehen, CH
Ulrich Hengst · New York, US
Denis Monard · Füllinsdorf, CH

Key dates

Filing date	Aug 30, 2001
Grant date	Apr 18, 2006
Priority date	—
Expiry date	Oct 30, 2022

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.